Yu Wen

1.0k total citations
28 papers, 796 citations indexed

About

Yu Wen is a scholar working on Molecular Biology, Electronic, Optical and Magnetic Materials and Cancer Research. According to data from OpenAlex, Yu Wen has authored 28 papers receiving a total of 796 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Electronic, Optical and Magnetic Materials and 6 papers in Cancer Research. Recurrent topics in Yu Wen's work include Nanoplatforms for cancer theranostics (6 papers), Gold and Silver Nanoparticles Synthesis and Applications (5 papers) and Adipokines, Inflammation, and Metabolic Diseases (5 papers). Yu Wen is often cited by papers focused on Nanoplatforms for cancer theranostics (6 papers), Gold and Silver Nanoparticles Synthesis and Applications (5 papers) and Adipokines, Inflammation, and Metabolic Diseases (5 papers). Yu Wen collaborates with scholars based in China, Canada and United States. Yu Wen's co-authors include Ming Li, Yangcenzi Xie, Chao Zheng, Xiaoming Su, Hongwei Wang, Katherine Cianflone, Vinh X. Truong, Huiling Lü, Tao Guo and Dedong Cao and has published in prestigious journals such as Cell, Advanced Materials and Nano Letters.

In The Last Decade

Yu Wen

26 papers receiving 790 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Wen China 17 337 255 137 103 99 28 796
Fuyan Wang China 20 586 1.7× 284 1.1× 217 1.6× 188 1.8× 187 1.9× 40 1.1k
Xing Zhong China 18 363 1.1× 155 0.6× 36 0.3× 90 0.9× 92 0.9× 78 850
Liting Guo China 18 302 0.9× 192 0.8× 132 1.0× 93 0.9× 137 1.4× 40 893
Jack Sharkey United Kingdom 13 240 0.7× 205 0.8× 37 0.3× 96 0.9× 65 0.7× 24 661
Kan Wang China 14 303 0.9× 246 1.0× 38 0.3× 32 0.3× 102 1.0× 46 897
Neil MacRitchie United Kingdom 18 466 1.4× 148 0.6× 53 0.4× 39 0.4× 47 0.5× 27 1.1k
Mayumi Ikeda Japan 16 242 0.7× 217 0.9× 36 0.3× 40 0.4× 103 1.0× 46 734
Xiaojing Zhang China 15 219 0.6× 213 0.8× 56 0.4× 62 0.6× 118 1.2× 52 905
Min Seok Song South Korea 15 255 0.8× 128 0.5× 50 0.4× 41 0.4× 113 1.1× 52 618
Zhengxia Liu China 16 278 0.8× 132 0.5× 41 0.3× 49 0.5× 77 0.8× 33 661

Countries citing papers authored by Yu Wen

Since Specialization
Citations

This map shows the geographic impact of Yu Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Wen more than expected).

Fields of papers citing papers by Yu Wen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Wen. The network helps show where Yu Wen may publish in the future.

Co-authorship network of co-authors of Yu Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Wen. A scholar is included among the top collaborators of Yu Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Wen. Yu Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Tian, Wei, Feng Guo, Yu Wen, et al.. (2025). Dosimetric evaluation of simplified intensity-modulated radiation therapy for thoracic tumors. Medicine. 104(9). e41738–e41738.
3.
Liu, Xiaohan, Wei Tian, Hui Li, et al.. (2025). A comparative analysis of toxicity and treatment outcomes of adaptive radiotherapy and intensity-modulated radiotherapy in cervical cancer. Scientific Reports. 15(1). 1609–1609. 1 indexed citations
4.
Wen, Yu, et al.. (2024). Analysis and study of transient characteristics of hydrogen circulation pump under different stopping modes. International Journal of Hydrogen Energy. 89. 1040–1048. 2 indexed citations
5.
Wen, Yu, Ruoxuan Liu, Yangcenzi Xie, & Ming Li. (2024). Targeted SERS Imaging and Intraoperative Real‐Time Elimination of Microscopic Tumors for Improved Breast‐Conserving Surgery. Advanced Materials. 36(32). e2405253–e2405253. 16 indexed citations
6.
Wen, Yu, et al.. (2024). An Active Self‐Mitochondria‐Targeting Cyanine Immunomodulator for Near‐Infrared II Fluorescence Imaging‐Guided Synergistic Photodynamic Immunotherapy. Advanced Healthcare Materials. 13(26). e2401061–e2401061. 8 indexed citations
7.
Dai, Yifan, Zhengqing Zhou, Yu Wen, et al.. (2024). Biomolecular condensates regulate cellular electrochemical equilibria. Cell. 187(21). 5951–5966.e18. 34 indexed citations
9.
Yang, Xiaoxin, Xiang Xu, Meifang Wang, et al.. (2022). A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin. Journal of Nanobiotechnology. 20(1). 230–230. 67 indexed citations
10.
Xie, Yangcenzi, Yu Wen, Xiaoming Su, Chao Zheng, & Ming Li. (2022). Label-Free Plasmon-Enhanced Spectroscopic HER2 Detection for Dynamic Therapeutic Surveillance of Breast Cancer. Analytical Chemistry. 94(37). 12762–12771. 22 indexed citations
11.
Lv, Chao, et al.. (2021). HOXD3 Up-regulating KDM5C Promotes Malignant Progression of Diffuse Large B-Cell Lymphoma by Decreasing p53 Expression. Balkan Medical Journal. 39(1). 30–38. 3 indexed citations
13.
Xue, Fei, Yanhui Liu, Hongwei Zhang, et al.. (2016). Let-7a enhances the sensitivity of hepatocellular carcinoma cells to cetuximab by regulating STAT3 expression. OncoTargets and Therapy. Volume 9. 7253–7261. 31 indexed citations
14.
Wen, Yu, Dedong Cao, Hao Zhou, Yu Hu, & Tao Guo. (2015). PGC-1α is responsible for survival of multiple myeloma cells under hyperglycemia and chemotherapy. Oncology Reports. 33(4). 2086–2092. 12 indexed citations
15.
Cao, Dedong, Hao Zhou, Jikai Zhao, et al.. (2014). PGC-1α integrates glucose metabolism and angiogenesis in multiple myeloma cells by regulating VEGF and GLUT-4. Oncology Reports. 31(3). 1205–1210. 22 indexed citations
16.
Wu, Yuwen, Jianhua Zhang, Yu Wen, et al.. (2008). Increased acylation-stimulating protein, C-reactive protein, and lipid levels in young women with polycystic ovary syndrome. Fertility and Sterility. 91(1). 213–219. 58 indexed citations
17.
Mi, Jie, Xiaoyuan Zhao, Meixian Zhang, et al.. (2008). Acylation stimulating protein but not complement C3 associates with metabolic syndrome components in Chinese children and adolescents. European Journal of Endocrinology. 159(6). 781–790. 21 indexed citations
18.
Wen, Yu, Hongwei Wang, Robin MacLaren, et al.. (2008). Sex steroid hormones induce acylation stimulating protein resistance in 3T3‐L1 adipocytes. Journal of Cellular Biochemistry. 105(2). 404–413. 22 indexed citations
19.
Wen, Yu, Hongwei Wang, Robin MacLaren, et al.. (2007). Palmitate and oleate induction of acylation stimulating protein resistance in 3T3‐L1 adipocytes and preadipocytes. Journal of Cellular Biochemistry. 104(2). 391–401. 28 indexed citations
20.
Cianflone, Katherine, Huiling Lü, Jessica Smith, Yu Wen, & Hongwei Wang. (2005). Adiponectin, acylation stimulating protein and complement C3 are altered in obesity in very young children. Clinical Endocrinology. 62(5). 567–572. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026